ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ilaris, Injektionslösung - 
66191001 PPNovartis Pharma Schweiz AG
Ilaris, Injektionslösung15.05.2017
  15.05.2017
Canakinumab (L04AC08) 
WHO-DDD 
07.10.99. 
07.15. 
A  
Yes 
IPCI
10377.33Yes
    
10 %10893.40
7680661910011Biotechnologika
7269811 
Composition
canakinumabum 150 mg, mannitolum, histidinum aut histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Canakinumabum150 mg/ml
BAG: Active AgentDose
Canakinumabum150 mg
 
Inactive agents
Histidinum aut Histidini Hydrochloridum Monohydricum
Mannitol
Polysorbatum 80
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home